Device type · MIH
System, Endovascular Graft, Aortic Aneurysm Treatment
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MIH
Cardiovascular
Device class
Class III
FDA decisions since 2015
14
510(k), De Novo and PMA
Adverse event reports
3,191
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- System, Endovascular Graft, Aortic Aneurysm Treatment
- Product code
- MIH
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Interventional Cardiology
- FDA record
- Classification database entry for MIH
Latest FDA decisions
The 8 newest of 14 since 2015.
- Zenith® Iliac BranchPMA supplement
P020018-S064 · Decided May 30, 2025 · 302 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- GORE®1 EXCLUDER® Conformable AAA Endoprosthesis (CEXC), GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC)PMA supplement
W. L. Gore and Associates, Inc.
P200030-S014 · Decided Apr 5, 2024 · 178 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- RelayPro Thoracic Stent-Graft SystemPMA supplement
P200045-S002 · Decided Mar 7, 2023 · 295 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- GORE TAG Thoracic Branch Endoprosthesis (TBE Device)BreakthroughPMA
P210032 · Decided May 13, 2022 · 262 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
P200045 · Decided Aug 5, 2021 · 258 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
W. L. Gore and Associates, Inc.
P200030 · Decided Dec 22, 2020 · 176 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
P190015 · Decided May 4, 2020 · 336 days after receipt
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- Alto Abdominal Stent Graft SystemPMA supplement
P120006-S031 · Decided Mar 13, 2020 · 366 days after receipt · Panel Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
Reports received
3,191
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
629
20% of reports
Injury reports
2,403
75% of reports
Death reports
158
5.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 51 | 213 | 14 | 0 |
| Jan 24 | 33 | 155 | 17 | 0 |
| Feb 24 | 53 | 178 | 11 | 0 |
| Mar 24 | 56 | 234 | 27 | 0 |
| Apr 24 | 46 | 174 | 28 | 0 |
| May 24 | 100 | 260 | 24 | 0 |
| Jun 24 | 49 | 182 | 17 | 0 |
| Jul 24 | 53 | 182 | 22 | 0 |
| Aug 24 | 84 | 203 | 9 | 0 |
| Sep 24 | 58 | 145 | 10 | 0 |
| Oct 24 | 51 | 206 | 22 | 0 |
| Nov 24 | 96 | 195 | 14 | 0 |
| Dec 24 | 63 | 240 | 23 | 0 |
| Jan 25 | 59 | 157 | 21 | 0 |
| Feb 25 | 54 | 190 | 19 | 0 |
| Mar 25 | 75 | 226 | 31 | 0 |
| Apr 25 | 54 | 200 | 24 | 0 |
| May 25 | 71 | 222 | 29 | 0 |
| Jun 25 | 57 | 204 | 18 | 0 |
| Jul 25 | 74 | 230 | 10 | 0 |
| Aug 25 | 38 | 166 | 9 | 0 |
| Sep 25 | 67 | 182 | 11 | 0 |
| Oct 25 | 53 | 199 | 11 | 0 |
| Nov 25 | 57 | 223 | 16 | 0 |
| Dec 25 | 57 | 215 | 17 | 0 |
| Jan 26 | 55 | 172 | 12 | 0 |
| Feb 26 | 51 | 194 | 16 | 0 |
| Mar 26 | 49 | 187 | 11 | 0 |
| Apr 26 | 60 | 219 | 15 | 0 |
| May 26 | 70 | 187 | 7 | 0 |
| Jun 26 | 49 | 211 | 16 | 0 |
| Jul 26 | 45 | 206 | 11 | 1 |
| Aug 26 | 34 | 190 | 12 | 0 |
| Sep 26 | 58 | 194 | 15 | 0 |
| Oct 26 | 44 | 205 | 10 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem974
- Device Endoleak403
- Leak/Splash311
- Patient-Device Incompatibility287
- Malposition of Device181
- Migration163
- Material Deformation123
- Obstruction of Flow99
- Detachment of Device or Device Component93
- Off-Label Use90
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Clinical Endoleak1,017
- No Clinical Signs, Symptoms or Conditions639
- Aneurysm expansion335
- Obstruction/Occlusion331
- Insufficient Information286
- Vascular Dissection216
- Aneurysm156
- Thrombosis/Thrombus143
- Ischemia100
- Unspecified Infection81
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2672-2026 · Started May 19, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to catheter separation
Cause as FDA categorized it: Under Investigation by firm
Z-2160-2026 · Started Apr 22, 2026 · Posted by FDA May 22, 2026
Reason given: Labeling update concerning proximal clasp disconnection from the outer control tube which may prevent stent graft from being released from the delivery system.
Cause as FDA categorized it: Under Investigation by firm
Z-0043-2026 · Started Sep 18, 2025 · Posted by FDA Oct 10, 2025
Reason given: Affected devices may contain PTFE coating scrapings. Scrapings could be released during device deployment, potentially causing intravascular embolization.
Cause as FDA categorized it: Process design
Z-1383-2024 · Started Feb 22, 2024 · Posted by FDA Mar 27, 2024
Reason given: The stent-graft inside the delivery system was the incorrect size.
Cause as FDA categorized it: Under Investigation by firm
Z-1689-2023 · Started May 3, 2023 · Posted by FDA Jun 6, 2023
Reason given: Potential for the incorrect size stent-graft than the printed carton label.
Cause as FDA categorized it: Process control
- RELAY PRO, THORACIC STENT-GRAFT SYSTEM, REF 28-M4-XX-XXX-XXXOpen, Classified
Z-0997-2023 · Started Dec 20, 2022 · Posted by FDA Jan 19, 2023
Reason given: The product may be shorter than packaging indicates
Cause as FDA categorized it: Labeling Change Control
- RELAY PRO, THORACIC STENT-GRAFT SYSTEM, REF 28-N4-XX-XXX-XXXOpen, Classified
Z-0998-2023 · Started Dec 20, 2022 · Posted by FDA Jan 19, 2023
Reason given: The product may be shorter than packaging indicates
Cause as FDA categorized it: Labeling Change Control
Z-0657-2022 · Started Dec 21, 2021
Reason given: Stent Graft Systems built with specific batches of taper tip assemblies have the potential for the taper tip to detach from the delivery system. Detachment of the taper tip during the implant procedure may lead to a secondary intervention to attempt to remove the taper tip, either by endovascular retrieval or surgical...
Cause as FDA categorized it: Nonconforming Material/Component
Showing the 8 newest of 176 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.